- De novo heterozygous pathogenic variants in NSD1 and ANKRD11 identified by trio genome sequencing in a six-year-old with developmental delay.
- Blended phenotype attenuated hallmark features of Sotos and KBG syndromes, preventing clinical suspicion of either syndrome.
- Findings highlight need for comprehensive genome-wide testing and integrated genetic counselling in atypical neurodevelopmental presentations.
Mol Genet Genomic Med. 2026 Nov;14(11):e70352. doi: 10.1002/mgg3.70352.
ABSTRACT
BACKGROUND: Dual molecular diagnoses involving pathogenic variants in multiple disease-associated genes are increasingly recognized with the widespread use of genome-wide sequencing; however, their clinical presentation and diagnostic challenges remain incompletely understood. We report a patient with a dual molecular diagnosis of Sotos syndrome and KBG syndrome.
METHODS: Trio-based genome sequencing was performed in a six-year-old girl with global developmental delay and nonspecific clinical features. Variants were interpreted according to ACMG/AMP guidelines.
RESULTS: The patient showed global developmental delay, intellectual disability (developmental quotient 53 at 5 years 10 months), hyperactivity, impulsivity, and sensory hypersensitivity. Growth was near average with delayed bone age. Hallmark features of both syndromes were attenuated or absent, and neither syndrome was clinically suspected. Genome sequencing identified de novo heterozygous pathogenic variants in NSD1 and ANKRD11. Intellectual disability severity was within the reported range for each syndrome.
CONCLUSION: This co-occurrence demonstrates that blended phenotypes may obscure diagnostic features, emphasizing the importance of comprehensive genomic testing and integrated clinical management, including genetic counseling, in atypical presentations.
PMID:43040894 | DOI:10.1002/mgg3.70352
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

